Search Results - "Kofler, D"

Adenosine receptor A2a blockade by caffeine increases IFN-gamma production in Th1 cells from patients with rheumatoid arthritis by Gloyer, L, Golumba-Nagy, V, Meyer, A, Yan, S, Schiller, J, Breuninger, M, Jochimsen, D, Kofler, D M

“…Studies indicate that caffeine uptake may be a risk factor for rheumatoid arthritis (RA), but a definitive link between caffeine consumption and RA has not…”
Get full text

CO2, CO, and CH4 measurements from tall towers in the NOAA Earth System Research Laboratory's Global Greenhouse Gas Reference Network: instrumentation, uncertainty analysis, and recommendations for future high-accuracy greenhouse gas monitoring efforts by Andrews, A E, Kofler, J D, Trudeau, M E, Williams, J C, Neff, D H, Masarie, K A, Chao, D Y, Kitzis, D R, Novelli, P C, Zhao, C L, Dlugokencky, E J, Lang, P M, Crotwell, M J, Fischer, M L, Parker, M J, Lee, J T, Baumann, D D, Desai, A R, Stanier, C O, De Wekker, S F. J, Wolfe, D E, Munger, J W, Tans, P P

“…A reliable and precise in situ CO2 and CO analysis system has been developed and deployed at eight sites in the NOAA Earth System Research Laboratory's (ESRL)…”
Get full text

Redirecting human CD4 CD25 regulatory T cells from the peripheral blood with pre-defined target specificity by Hombach, A A, Kofler, D, Rappl, G, Abken, H

“…Recent insight into the balance of self-tolerance and auto-aggression has raised interest in using human regulatory T (Treg) cells for adoptive immunotherapy…”
Get full text

Targeting lipid metabolism by the lipoprotein lipase inhibitor orlistat results in apoptosis of B-cell chronic lymphocytic leukemia cells by Pallasch, C P, Schwamb, J, Königs, S, Schulz, A, Debey, S, Kofler, D, Schultze, J L, Hallek, M, Ultsch, A, Wendtner, C-M

“…Constitutively activated pathways contribute to apoptosis resistance in chronic lymphocytic leukemia (CLL). Little is known about the metabolism of lipids and…”
Get full text

Phase 1b trial of atacicept, a recombinant protein binding BLyS and APRIL, in patients with chronic lymphocytic leukemia by Kofler, D M, Gawlik, B B, Elter, T, Gianella-Borradori, A, Wendtner, C-M, Hallek, M

Get full text

Current status of immunotherapy in B cell malignancies by Kofler, D M, Mayr, C, Wendtner, C-M

“…Conventional treatment of hematologic malignancies mainly consists of chemotherapeutic agents or a combination of both, chemotherapy and monoclonal antibodies…”
Get more information

Engagement of the B-cell antigen receptor (BCR) allows efficient transduction of ZAP-70-positive primary B-CLL cells by recombinant adeno-associated virus (rAAV) vectors by KOFLER, D. M, BÜNING, H, MAYR, C, BUND, D, BAUMERT, J, HALLEK, M, WENDTNER, C-M

“…Engagement of the B-cell antigen receptor (BCR) by crosslinking of the surface immunoglobulin (sIg) homodimer was studied for recombinant adeno-associated…”
Get full text

The Potential of Gene Transfer into Primary B-CLL Cells Using Recombinant Virus Vectors by Wendtner, C-M, Kofler, DM, Mayr, C, Bund, D, Hallek, M

“…Despite recent advances, chronic lymphocytic leukemia (CLL) as the most common leukemia remains a largely incurable disease. Modern treatment options include…”
Get full text

Narrow-band measurement of differential group delay by a six-state RF phase-shift technique: 40 fs single-measurement uncertainty by Williams, P.A., Kofler, J.D.

“…We describe in detail our implementation of a modulation phase shift (MPS) technique for narrow-bandwidth measurement of differential group delay (DGD) and the…”
Get full text

CO 2 , CO, and CH 4 measurements from tall towers in the NOAA Earth System Research Laboratory's Global Greenhouse Gas Reference Network: instrumentation, uncertainty analysis, and recommendations for future high-accuracy greenhouse gas monitoring efforts by Andrews, A. E., Kofler, J. D., Trudeau, M. E., Williams, J. C., Neff, D. H., Masarie, K. A., Chao, D. Y., Kitzis, D. R., Novelli, P. C., Zhao, C. L., Dlugokencky, E. J., Lang, P. M., Crotwell, M. J., Fischer, M. L., Parker, M. J., Lee, J. T., Baumann, D. D., Desai, A. R., Stanier, C. O., De Wekker, S. F. J., Wolfe, D. E., Munger, J. W., Tans, P. P.

“…A reliable and precise in situ CO2 and CO analysis system has been developed and deployed at eight sites in the NOAA Earth System Research Laboratory's (ESRL)…”
Get full text

Gene transfer preferentially selects MHC class I positive tumour cells and enhances tumour immunogenicity by HACKER, Ulrich T, SCHILDHAUER, Ines, BARROSO, Margarita Céspedes, KOFLER, David M, GERNER, Franz M, MYSLIWIETZ, Josef, BUENING, Hildegard, HALLEK, Michael, KING, Susan B. S

“…The modulated expression of MHC class I on tumour tissue is well documented. Although the effect of MHC class I expression on the tumorigenicity and…”
Get full text

Phase 1 b trial of atacicept, a recombinant protein binding BLyS and APRIL, in patients with chronic lymphocytic leukemia by KOFLER, D. M, GAWLIK, B. B, ELTER, T, GIANELLA-BORRADORI, A, WENDTNER, C.-M, HALLEK, M

Get full text

Redirecting human [CD4.sup.+][CD25.sup.+] regulatory T cells from the peripheral blood with pre-defined target specificity by Hombach, A.A, Kofler, D, Rappl, G, Abken, H

“…Recent insight into the balance of self-tolerance and auto-aggression has raised interest in using human regulatory T (Treg) cells for adoptive immunotherapy…”
Get full text

Redirecting human CD4 super(+)CD25 super(+) regulatory T cells from the peripheral blood with pre-defined target specificity by Hombach, A A, Kofler, D, Rappl, G, Abken, H

“…Recent insight into the balance of self-tolerance and auto-aggression has raised interest in using human regulatory T (Treg) cells for adoptive immunotherapy…”
Get full text

Vero cytotoxin-producing Escherichia coli O157 infections in Austria by Sölder, B, Allerberger, F, Eigentler, A, Köfler, D, Larcher, C, Dierich, M P, Rowe, B

“…To determine the prevalence of Vero cytotoxin-producing Escherichia coli (VTEC) serotype O157 associated diarrhea in the Austrian patient population, we…”
Get more information

Application of the tyrosinase assay to normal melanocytes in culture by Auböck, J, Köfler, D, Sifter, M, Fritsch, P

“…Using a special selection technique, normal guinea-pig melanocytes were maintained in highly purified but sparse cultures (approximately 10(4) cells/25 cm2…”
Get more information

A phase Ib trial of atacicept (TACI-Ig) to neutralize APRIL and BLyS in patients with refractory or relapsed B-cell chronic lymphocytic leukemia (B-CLL) by Kofler, D. M., Elter, T., Gianella-Borradori, A., Busby, S., Wendtner, C. M., Hallek, M.

“…Abstract only 3029 Background: B-CLL cells are resistant to apoptosis and thus exhibit prolonged survival and accumulation in vivo. Exogenously added soluble…”
Get full text

Abatacept inhibits inflammation and onset of rheumatoid arthritis in individuals at high risk (ARIAA): a randomised, international, multicentre, double-blind, placebo-controlled trial by Rech, Juergen, Tascilar, Koray, Hagen, Melanie, Kleyer, Arnd, Manger, Bernhard, Schoenau, Verena, Hueber, Axel J, Kleinert, Stefan, Baraliakos, Xenofon, Braun, Jürgen, Kiltz, Uta, Fleck, Martin, Rubbert-Roth, Andrea, Kofler, David M, Behrens, Frank, Feuchtenberger, Martin, Zaenker, Michael, Voll, Reinhard, Venhoff, Nils, Thiel, Jens, Glaser, Cornelia, Feist, Eugen, Burmester, Gerd R, Karberg, Kirsten, Strunk, Johannes, Cañete, Juan D, Senolt, Ladislav, Filkova, Maria, Naredo, Esperanza, Largo, Raquel, Krönke, Gerhard, D'Agostino, Maria-Antonietta, Østergaard, Mikkel, Schett, Georg

“…Individuals with anti-citrullinated protein antibodies (ACPAs) and subclinical inflammatory changes in joints are at high risk of developing rheumatoid…”
Get full text

Chromosomal translocations are associated with poor prognosis in chronic lymphocytic leukemia by Mayr, Christine, Speicher, Michael R., Kofler, David M., Buhmann, Raymund, Strehl, John, Busch, Raymonde, Hallek, Michael, Wendtner, Clemens-Martin

“…In chronic lymphocytic leukemia (CLL), chromosomes usually evade detailed cytogenetic analyses because cells poorly respond to the traditionally used set of…”
Get full text

High incidence of new translocations in B-CLL detected by CD40L-enhanced cytogenetics (CEC): A new prognostic marker for infavorable survival outcome in patients with B-CLL by Mayr, C., Schoch, C., Kofler, D. M., Busch, R., Hallek, M., Wendtner, C.-M.

“…Abstract only…”
Get full text